Biography
Milana Frenkel-Morgenstern
Bar-Ilan University, Israel
Dr.
Milana Frenkel-Morgenstern has completed her Ph. D at the age of 32 years from
Weizmann Institute of Science and postdoctoral studies from Spanish National
Cancer Research Centre (CNIO). She has published more than 25 papers in reputed
journals and serving as an editorial board member of repute. She is a founder
of the Art in Science competition at the ISMB conference since 2008; a chair of
the ISCB affiliated Israeli Bioinformatics group, and a head of the Cancer
Genomics and BioComputing group in the Azrieli faculty of Medicine, Bar-Ilan
University.
Research Interest:
Her
Research Interest includes the development of a Liquid Biopsy platform for
brain cancers using unique biomarkers, particularly, fusion proteins. We expect
to provide a proof-of-concept stage of our research for 50 patients in
glioblastoma, and the validation stage for 1000 patients in gliomas.